Literature DB >> 9890180

More about: irinotecan-related cholinergic syndrome induced by coadministration of oxaliplatin.

H M Dodds, J F Bishop, L P Rivory.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9890180     DOI： 10.1093/jnci/91.1.91a

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  4 in total

Review 1.  Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies.

Authors:  C R Culy; D Clemett; L R Wiseman
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

Review 2.  Camptothecin and podophyllotoxin derivatives: inhibitors of topoisomerase I and II - mechanisms of action, pharmacokinetics and toxicity profile.

Authors:  Jörg T Hartmann; Hans-Peter Lipp
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 3.  Pancreatic cancer and FOLFIRINOX: a new era and new questions.

Authors:  Robert De W Marsh; Mark S Talamonti; Matthew Harold Katz; Joseph M Herman
Journal:  Cancer Med       Date:  2015-02-19       Impact factor: 4.452

Review 4.  Standardization of the infusion sequence of antineoplastic drugs used in the treatment of breast and colorectal cancers.

Authors:  Amanda Alves da Silva; Juliane Carlotto; Inajara Rotta
Journal:  Einstein (Sao Paulo)       Date:  2018-06-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.